Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections
April 18, 2024 16:10 ET
|
Barinthus Biotherapeutics
Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today announced topline final data from the APOLLO trial (also known as HPV001).
New Study Reveals Potential Treatment for Neurological Lyme Disease
April 18, 2024 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study...
OPTIZMO™ Releases 2023 Email Opt-Out Infographic
April 18, 2024 09:00 ET
|
OPTIZMO Technologies, LLC
The infographic presents unique insights and data from hundreds of millions of opt-out requests, focusing on timing, geographic location, and device usage.
Digital Utilities Ventures Completes Strategic Merger - Paving the Way for Future Growth and Innovation
April 18, 2024 09:00 ET
|
Digital Utilities Ventures, Inc.
Digital Utilities Ventures Completes Strategic Merger - Paving the Way for Future Growth and Innovation
Anaqua macht ausländische Patentanmeldungen zu einem strategischen Vorteil für IP-Profis
April 18, 2024 07:00 ET
|
Anaqua
BOSTON / MÜNCHEN, April 18, 2024 (GLOBE NEWSWIRE) -- Anaqua, der führende Anbieter von Innovations- und IP-Management-Technologien, kündigt die Weiterentwicklung seines Angebots für...
アナクアが外国特許出願を戦略的アドバンテージに変える 機能・サービス強化を発表
April 18, 2024 07:00 ET
|
Anaqua
ボストン, April 18, 2024 (GLOBE NEWSWIRE) --...
Anaqua transforme l’extension de brevets à l’international en avantage stratégique pour les professionnels de la PI
April 18, 2024 07:00 ET
|
Anaqua
BOSTON, 18 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) pour les entreprises, les conseils et les administrations, annonce...
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
April 18, 2024 07:00 ET
|
Anaqua
Anaqua revolutionizes IP management with enhanced Foreign Filing in AQX®, empowering swift global protection decisions.
Renewables and nascent low-carbon technologies most exposed to high interest rates
April 18, 2024 06:25 ET
|
Wood Mackenzie
NEWS RELEASE Renewables and nascent low-carbon technologies most exposed to high interest rates Policymakers should...
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
April 17, 2024 10:15 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most...